Literature DB >> 19876674

Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia.

A T Gloster1, H U Wittchen, F Einsle, M Höfler, T Lang, S Helbig-Lang, T Fydrich, L Fehm, A O Hamm, J Richter, G W Alpers, A L Gerlach, A Ströhle, T Kircher, J Deckert, P Zwanzger, V Arolt.   

Abstract

Cognitive behavioral therapy (CBT) is efficacious for panic disorder with agoraphobia (PD/A). Nevertheless, the active ingredients of treatment and the mechanisms through which CBT achieves its effects remain largely unknown. The mechanisms of action in CBT (MAC) study was established to investigate these questions in 369 patients diagnosed with PD/A. The MAC study utilized a multi-center, randomized controlled design, with two active treatment conditions in which the administration of exposure was varied, and a wait-list control group. The special feature of MAC is the way in which imbedded experimental, psychophysiological, and neurobiological paradigms were included to elucidate therapeutic and psychopathological processes. This paper describes the aims and goals of the MAC study and the methods utilized to achieve them. All aspects of the research design (e.g., assessments, treatment, experimental procedures) were implemented so as to facilitate the detection of active therapeutic components, and the mediators and moderators of therapeutic change. To this end, clinical, behavioral, physiological, experimental, and genetic data were collected and will be integrated.

Entities:  

Mesh:

Year:  2009        PMID: 19876674     DOI: 10.1007/s00406-009-0065-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  24 in total

Review 1.  Neuroanatomical hypothesis of panic disorder, revised.

Authors:  J M Gorman; J M Kent; G M Sullivan; J D Coplan
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

2.  Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder.

Authors:  J Deckert; M Catalano; Y V Syagailo; M Bosi; O Okladnova; D Di Bella; M M Nöthen; P Maffei; P Franke; J Fritze; W Maier; P Propping; H Beckmann; L Bellodi; K P Lesch
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

3.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

4.  Neural systems involved in fear and anxiety measured with fear-potentiated startle.

Authors:  Michael Davis
Journal:  Am Psychol       Date:  2006-11

Review 5.  Optimizing inhibitory learning during exposure therapy.

Authors:  Michelle G Craske; Katharina Kircanski; Moriel Zelikowsky; Jayson Mystkowski; Najwa Chowdhury; Aaron Baker
Journal:  Behav Res Ther       Date:  2007-10-07

6.  The Claustrophobia Questionnaire.

Authors:  A S Radomsky; S Rachman; D S Thordarson; H K McIsaac; B A Teachman
Journal:  J Anxiety Disord       Date:  2001 Jul-Aug

7.  Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.

Authors:  D H Barlow; J M Gorman; M K Shear; S W Woods
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

8.  Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder.

Authors:  Katharina Domschke; Miriam Braun; Patricia Ohrmann; Thomas Suslow; Harald Kugel; Jochen Bauer; Christa Hohoff; Anette Kersting; Almut Engelien; Volker Arolt; Walter Heindel; Jürgen Deckert
Journal:  Int J Neuropsychopharmacol       Date:  2005-09-05       Impact factor: 5.176

9.  Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder.

Authors:  Tina B Lonsdorf; Almut I Weike; Pernilla Nikamo; Martin Schalling; Alfons O Hamm; Arne Ohman
Journal:  Psychol Sci       Date:  2009-01-23

10.  And yet they correlate: psychophysiological activation predicts self-report outcomes of exposure therapy in claustrophobia.

Authors:  Georg W Alpers; Roxane Sell
Journal:  J Anxiety Disord       Date:  2007-11-21
View more
  23 in total

Review 1.  Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder.

Authors:  Thomas Dresler; Anne Guhn; Sara V Tupak; Ann-Christine Ehlis; Martin J Herrmann; Andreas J Fallgatter; Jürgen Deckert; Katharina Domschke
Journal:  J Neural Transm (Vienna)       Date:  2012-06-13       Impact factor: 3.575

2.  Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms.

Authors:  Sebastian Trautmann; Jan Richter; Markus Muehlhan; Michael Höfler; Hans-Ulrich Wittchen; Katharina Domschke; Andreas Ströhle; Alfons O Hamm; Heike Weber; Tilo Kircher; Volker Arolt; Alexander L Gerlach; Georg W Alpers; Thomas Fydrich; Thomas Lang; Andreas Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-15       Impact factor: 5.270

3.  Optimizing exposure-based CBT for anxiety disorders via enhanced extinction: Design and methods of a multicentre randomized clinical trial.

Authors:  Ingmar Heinig; Andre Pittig; Jan Richter; Katrin Hummel; Isabel Alt; Kristina Dickhöver; Jennifer Gamer; Maike Hollandt; Katja Koelkebeck; Anne Maenz; Sophia Tennie; Christina Totzeck; Yunbo Yang; Volker Arolt; Jürgen Deckert; Katharina Domschke; Thomas Fydrich; Alfons Hamm; Jürgen Hoyer; Tilo Kircher; Ulrike Lueken; Jürgen Margraf; Peter Neudeck; Paul Pauli; Winfried Rief; Silvia Schneider; Benjamin Straube; Andreas Ströhle; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2017-03-21       Impact factor: 4.035

Review 4.  Real-time fMRI neurofeedback: progress and challenges.

Authors:  J Sulzer; S Haller; F Scharnowski; N Weiskopf; N Birbaumer; M L Blefari; A B Bruehl; L G Cohen; R C DeCharms; R Gassert; R Goebel; U Herwig; S LaConte; D Linden; A Luft; E Seifritz; R Sitaram
Journal:  Neuroimage       Date:  2013-03-27       Impact factor: 6.556

5.  5HTT is associated with the phenotype psychological flexibility: results from a randomized clinical trial.

Authors:  Andrew T Gloster; Alexander L Gerlach; Alfons Hamm; Michael Höfler; Georg W Alpers; Tilo Kircher; Andreas Ströhle; Thomas Lang; Hans-Ulrich Wittchen; Jürgen Deckert; Andreas Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-01-15       Impact factor: 5.270

6.  Neural correlates of aversive conditioning: development of a functional imaging paradigm for the investigation of anxiety disorders.

Authors:  Isabelle Reinhardt; Andreas Jansen; Thilo Kellermann; André Schüppen; Nils Kohn; Alexander L Gerlach; Tilo Kircher
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-11       Impact factor: 5.270

7.  A new paradigm (Westphal-Paradigm) to study the neural correlates of panic disorder with agoraphobia.

Authors:  A Wittmann; F Schlagenhauf; T John; A Guhn; H Rehbein; A Siegmund; M Stoy; D Held; I Schulz; L Fehm; T Fydrich; A Heinz; H Bruhn; A Ströhle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-11-27       Impact factor: 5.270

8.  GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder.

Authors:  J Deckert; H Weber; C Villmann; T B Lonsdorf; J Richter; M Andreatta; A Arias-Vasquez; L Hommers; L Kent; C Schartner; S Cichon; C Wolf; N Schaefer; C R von Collenberg; B Wachter; R Blum; D Schümann; R Scharfenort; J Schumacher; A J Forstner; C Baumann; M A Schiele; S Notzon; P Zwanzger; J G E Janzing; T Galesloot; L A Kiemeney; A Gajewska; E Glotzbach-Schoon; A Mühlberger; G Alpers; T Fydrich; L Fehm; A L Gerlach; T Kircher; T Lang; A Ströhle; V Arolt; H-U Wittchen; R Kalisch; C Büchel; A Hamm; M M Nöthen; M Romanos; K Domschke; P Pauli; A Reif
Journal:  Mol Psychiatry       Date:  2017-02-07       Impact factor: 15.992

9.  MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy.

Authors:  A Reif; J Richter; B Straube; M Höfler; U Lueken; A T Gloster; H Weber; K Domschke; L Fehm; A Ströhle; A Jansen; A Gerlach; M Pyka; I Reinhardt; C Konrad; A Wittmann; B Pfleiderer; G W Alpers; P Pauli; T Lang; V Arolt; H-U Wittchen; A Hamm; T Kircher; J Deckert
Journal:  Mol Psychiatry       Date:  2013-01-15       Impact factor: 15.992

10.  Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing.

Authors:  H Weber; J Richter; B Straube; U Lueken; K Domschke; C Schartner; B Klauke; C Baumann; C Pané-Farré; C P Jacob; C-J Scholz; P Zwanzger; T Lang; L Fehm; A Jansen; C Konrad; T Fydrich; A Wittmann; B Pfleiderer; A Ströhle; A L Gerlach; G W Alpers; V Arolt; P Pauli; H-U Wittchen; L Kent; A Hamm; T Kircher; J Deckert; A Reif
Journal:  Mol Psychiatry       Date:  2015-09-01       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.